Comparative Evaluation of Marketed Formulation of Antiparkinson Agents
Du sparer
0%
ift. normalprisen
Spar
0%
- Indbinding:
- Paperback
- Sideantal:
- 112
- Udgivet:
- 26. juli 2018
- Størrelse:
- 150x7x220 mm.
- Vægt:
- 185 g.
- 2-3 uger.
- 21. december 2024
På lager
Forlænget returret til d. 31. januar 2025
Normalpris
Abonnementspris
- Rabat på køb af fysiske bøger
- 1 valgfrit digitalt ugeblad
- 20 timers lytning og læsning
- Adgang til 70.000+ titler
- Ingen binding
Abonnementet koster 75 kr./md.
Ingen binding og kan opsiges når som helst.
- 1 valgfrit digitalt ugeblad
- 20 timers lytning og læsning
- Adgang til 70.000+ titler
- Ingen binding
Abonnementet koster 75 kr./md.
Ingen binding og kan opsiges når som helst.
Beskrivelse af Comparative Evaluation of Marketed Formulation of Antiparkinson Agents
Parkinson's disease is a progressive nervous system disorder that affects movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement. In the early stages of Parkinson's disease, your face may show little or no expression. Your arms may not swing when you walk. Your speech may become soft or slurred. Parkinson's disease symptoms worsen as your condition progresses over time. Although Parkinson's disease can't be cured, medications might significantly improve your symptoms. Occasionally, your doctor may suggest surgery to regulate certain regions of your brain and improve your symptoms.
Brugerbedømmelser af Comparative Evaluation of Marketed Formulation of Antiparkinson Agents
Giv din bedømmelse
For at bedømme denne bog, skal du være logget ind.Andre købte også..
Find lignende bøger
Bogen Comparative Evaluation of Marketed Formulation of Antiparkinson Agents findes i følgende kategorier:
© 2024 Pling BØGER Registered company number: DK43351621